Exploring standards of care in real-world settings with RWD
Real-world data (RWD) can help to illuminate patterns in therapy selection and the correlation to outcomes, giving oncologists and researchers some additional guidance on emerging trends in the oncology community.
From Data to Discovery: How AI Is Accelerating Progress in Oncology
the latest wave of data, technology, and artificial intelligence (AI) advances are challenging views, empowering individuals across life sciences functions to answer research questions using many different types of RWD
How COTA and Komodo Health Combine Real-World Datasets for Better Patient Insights
Komodo Health and COTA teamed up to link COTA’s high-quality oncology data with Komodo’s vast Healthcare MapTM
Getting personal with real-world data at ViVE 2024
At ViVE 2024 in Los Angeles, COTA’s Chief Medical Officer, C.K. Wang, MD will take part in a discussion session called “Data That’s Getting Personal”.
3 traits to look for in an oncology real-world data partner
Before raw, real-world data (RWD) can be transformed into actionable insights, it has to go through a number of different processes, from aggregation and abstraction to standardization and careful curation.
For the hematology community, AI and RWD are top of mind
A huge number of new breakthroughs in drug development, treatment guidelines, and decision support technologies occur every day to treat blood cancers.
LLMs aren’t good enough at diagnostics yet. What will it take to get them there?
Large language models (LLMs) are the foundation of highly hyped generative AI tools like Chat-GPT and Google Bard.
What’s in store for 2024? Generative AI, digital health funding, and real-world data
To ring in the new year, we asked COTA’s leadership team about their top predictions for 2024 in the oncology, real-world data, and life sciences spaces.
Women in Health Innovation: Deloitte x COTA blog series
In our blog series with Deloitte, we have written extensively about the benefits of using Real World Data to enhance clinical trials and accelerate research into new therapies for a variety of conditions.
COTA and Aetion partner to expand access to real-world data for oncology research
This collaboration enables Aetion and COTA to meet the needs of researchers requiring high-quality, clinically rich oncology data, for both liquid and solid tumor types.